Markets
National Highways Contract: India Infrastructure Project
Infrastructure Project Contract Analyzed Artefact Projects, alongside Pioneer Infra Consultants and Neoteric Consultant LLP, has secured a significant contract with the National Highways Authority of....
Alembic Pharmaceuticals Travoprost Approval – Generic Glaucoma Treatment
Alembic Pharmaceuticals’ Travoprost Approval Analyzed Alembic Pharmaceuticals has successfully gained final approval from the US Food & Drug Administration (USFDA) for a generic version of....
Tata Motors Share Price: Analysis & Forecast
Tata Motors Share Price Analyzed Key Points Tata Motors stock jumped 4% due to strong business forecasts. December 2025 saw a 14% rise, outperforming the....
Sun Pharma Stock Analysis: FDA Issues and Future Outlook
Sun Pharma Shares Analyzed Sun Pharma’s stock price dropped significantly on Thursday, falling by over 2%. This happened after the US Food and Drug Administration....
Emkay Upgrades Vedanta Outlook: HZ Upside Potential
Emkay Analyzes Vedanta Upside Emkay Global Financial Services (Emkay) has found a surprising reason to believe Vedanta’s earnings could be much higher than expected. They’re....
Meesho Stock Performance Analysis
Meesho Stock Performance Analyzed Meesho’s stock price has had a volatile week after its successful initial public offering (IPO). Initially, the stock soared, briefly reaching....
Oil Marketing Stocks Fall: Analysis of JM Financial Forecast
Oil Marketing Companies’ Stocks Fall: An Analysis Shares of companies that sell gasoline and diesel (oil marketing companies or OMCs) dropped sharply on Thursday. The....
Asian Markets Volatility – Updates & Analysis
Asian Markets Analyzed: Volatility and Key Updates Asian stock markets took a hit on Thursday, with declines spreading across the region. This was largely due....
Gujarat Kidney IPO: Key Details & Risks
Gujarat Kidney IPO Analyzed The Gujarat Kidney and Super Speciality healthcare company is offering shares to the public for the first time. This means they....
Sun Pharma Stock Decline: FDA OAI Investigation
Sun Pharmaceutical’s Decline Analyzed: A Key Update Sun Pharmaceutical Industries saw its stock price drop by 2.68% to Rs 1746.95 following news from the U.S.....
